MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 259 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.47 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $1,645,769 | +7.1% | 6,163 | -7.2% | 0.03% | +6.5% |
| Q4 2023 | $1,537,290 | +75.9% | 6,644 | +11.0% | 0.03% | +72.2% |
| Q3 2023 | $873,759 | -10.6% | 5,983 | +41.4% | 0.02% | -5.3% |
| Q2 2023 | $977,592 | -2.3% | 4,232 | +2.4% | 0.02% | 0.0% |
| Q1 2023 | $1,001,019 | +131.7% | 4,132 | -23.5% | 0.02% | +216.7% |
| Q3 2021 | $432,000 | +70.1% | 5,404 | +107.6% | 0.01% | +100.0% |
| Q2 2021 | $254,000 | – | 2,603 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paulson & Co. | 1,850,000 | $518,296,000 | 38.31% |
| Tao Capital Management LP | 130,529 | $36,569,005 | 29.98% |
| University of Wisconsin Foundation | 45,730 | $12,811,717 | 14.42% |
| AlpInvest Partners B.V. | 84,595 | $23,700,135 | 8.50% |
| RTW INVESTMENTS, LP | 1,915,862 | $536,747,898 | 8.31% |
| Propel Bio Management, LLC | 43,032 | $12,055,845 | 7.82% |
| Avoro Capital Advisors LLC | 2,055,555 | $575,884,289 | 7.67% |
| Baker Brothers Advisors | 1,974,590 | $553,201,134 | 7.07% |
| Tri Locum Partners LP | 65,352 | $18,309,016 | 4.63% |
| TCG Crossover Management, LLC | 149,283 | $41,823,125 | 4.36% |